Oclacitinib Maleate

CAS: 1640292-55-2

Ref. 3D-QQC29255

Produktinformation

• Name: Oclacitinib Maleate

Beschreibung

Oclacitinib Maleate is an orally-bioavailable small molecule drug candidate that inhibits the activity of the protein tyrosine kinase, which is a key signaling molecule in many cancers. Studies have shown that oclacitinib binds to the phosphate group on the ATP-binding site of the enzyme, preventing it from binding to its receptor. Oclacitinib has been shown to be safe and well tolerated for long-term use in diabetic patients. This drug has also been shown to inhibit PDL1 expression and inhibit insulin-like growth factor 1 (IGF1).

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 453.51 g/mol
• Formel: C₁₉H₂₇N₅O₆S
• Reinheit: Min. 95%